Investor Relations

RSS Content

Vanda Pharmaceuticals Announces Participation at November 2016 Investor Conferences

WASHINGTON, Nov. 14, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it will participate at the following upcoming investor conferences in November 2016.

The Stifel 2016 Healthcare Conference in New York City on Tuesday, November 15, 2016. A corporate presentation is scheduled for 8:45 a.m. Eastern Time.

The Jefferies 2016 London Healthcare Conference in London, England on November 16-17, 2016.   A corporate presentation is scheduled for Wednesday November 16, 2016 at 4:40 p.m. Greenwich Mean Time (11:40 a.m. Eastern Time).

The 28th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, November 29, 2016. A corporate presentation is scheduled for 11:00 a.m. Eastern Time.

The corporate presentations given at the Stifel, Jefferies and Piper conferences will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentations.

About Vanda Pharmaceuticals Inc.

Vanda is a biopharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2016-investor-conferences-300362418.html

SOURCE Vanda Pharmaceuticals Inc.

  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy